Developer docs
API playgroundTry for free, no card

Search company profiles

The Moran Company

Full company profile

uuid000u7tb

Namestring
The Moran Company
Legal namestring
The Moran Company
Websiteurl
themorancompany.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

The Moran Company is a private, for-profit healthcare research and consulting firm founded in 1997 and headquartered in Arlington, Virginia, United States. Per its firmographic record, it operates at the boundary between the public and private sectors in healthcare, positioning itself as a specialized boutique advisory in a niche policy/research intersection. The firm maintains a small headcount of 11-50 employees and operates without disclosed funding rounds, parent entities, subsidiaries, or M&A history. Its website (www.themorancompany.com) is the only publicly cited channel, and no customer logos, case studies, awards, patents, partnerships, or leadership roster are disclosed in the available sources. The firm's core technology is listed as 'Not disclosed,' and no products, services detail, or pricing model are publicly available.

A material data conflict exists across sources: while firmographic data describes The Moran Company as a healthcare research and consulting firm, one independent source characterizes it as a nonprofit fundraising consultancy. The healthcare characterization is treated as primary because it appears in the structured firmographic record and is consistent with the company's own materials; the characterization is treated as either an unreliable signal or a reference to an unrelated entity. This conflict represents a meaningful gap that limits the precision of any external due diligence.

Given the absence of disclosed financials, customer references, service line detail, or management team information, the firm's business model, go-to-market mechanics, and revenue composition cannot be substantively described. The most defensible characterization is that it is a small, private, long-tenured healthcare policy/research consultancy whose specific service mix, client roster, and financial profile are not publicly documented in the supplied data.

Short descriptiontext

The Moran Company is a private healthcare research and consulting firm founded in 1997 in Arlington, Virginia, operating at the boundary between the public and private sectors in healthcare. It runs as a small boutique with 11-50 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersArlington, United States
HQ citystring
Arlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
health care consulting, public policy research, health program analysis, regulatory advisory, health sector research
NAICS code3 codes
  • 54161
  • 5416
  • 541
SIC code2 codes
  • 8742
  • 8700
Product category
Healthcare Consulting
Social media profiles1 record
Cost components1 value
Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Moran Company is a health care research and consulting firm that delivers advisory and research services at the intersection of the public and private sectors in health care. It supports organizations navigating policy, reimbursement, regulatory, and program-design challenges across the public-private health care boundary.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Health Care Research and Consulting Services
CategoryHealthcare Consulting
Description

Research and advisory consulting services for organizations operating at the intersection of public and private health care sectors, supporting work in policy, reimbursement, regulation, and program design.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1Manatt Health
TypeDirect peer
Description

Manatt Health is the healthcare arm of Manatt, Phelps & Phillips, providing consulting and legal/regulatory advisory to health systems, plans, states, and federal agencies. It overlaps with Moran on Medicare/Medicaid policy, payment models, and strategy engagements for similar clients.

2Health Management Associates (HMA)
TypeDirect peer
Description

HMA is a healthcare research and consulting firm that advises payers, providers, states, and federal agencies on Medicaid, Medicare, and broader health policy. Like The Moran Company, it operates at the public/private intersection of US healthcare; HMA is materially larger but most directly comparable on dimension of service offering and end clients.

3The Lewin Group
TypeDirect peer
Description

Lewin Group is a healthcare policy consulting and research practice advising federal agencies, states, health plans, and providers on payment, delivery system, and program design questions. Its research-driven approach at the public/private intersection places it as a close analogue to Moran.

4Avalere Health
TypeDirect peer
Description

Avalere is a healthcare consulting and advisory firm focused on federal healthcare programs, reimbursement, and policy strategy. It serves the same payer, provider, and life-sciences clients with similar public/private sector advisory work, making it a strong direct comparison for Moran's policy and reimbursement analysis capabilities.

5Wakely Consulting Group
TypeDirect peer
Description

Wakely is a healthcare actuarial and consulting firm serving health plans, providers, and federal/state agencies on Medicare, Medicaid, and ACA programs. Like Moran, it combines quantitative consulting with policy understanding for similar end clients in the public/private healthcare nexus.

6Leavitt Partners
TypeDirect peer
Description

Leavitt Partners provides healthcare consulting and value-based-care strategy advisory to providers, payers, employers, and federal/state agencies. Shared positioning at the intersection of policy and commercial healthcare delivery makes it a relevant direct peer for similar consulting engagements.

7Advisory Board (now part of Optum)
TypeBroad incumbent
Description

Advisory Board (Optum) is a large healthcare research and consulting firm serving hospital systems, payers, and life sciences. While broader in scope and substantially larger, its policy and strategy research offerings overlap with Moran's healthcare advisory scope.

8Dobson DaVanzo & Associates
TypeEmerging player
Description

Dobson | DaVanzo is a healthcare economics and policy consulting firm providing reimbursement modeling, regulatory impact analysis, and litigation support to providers, payers, and government. Its reimbursement and policy-analytics focus mirrors a specific dimension of Moran's practice.

9Burns & Associates (now part of HMA)
TypeDirect peer
Description

Burns & Associates is a health policy consulting firm serving state Medicaid agencies, health plans, and providers on payment, eligibility, and program design. It is a strong comparable given shared state/federal Medicaid policy advisory depth.

10Health Policy Source
TypeEmerging player
Description

Health Policy Source is a Washington-area healthcare policy and reimbursement consulting firm serving providers, payers, and associations. Its specialty focus on payment policy and reimbursement strategy makes it a small-shop comparable in the same federal-program consulting niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Moran Company

Healthcare Consultingthemorancompany.com

The Moran Company is a private healthcare research and consulting firm founded in 1997 in Arlington, Virginia, operating at the boundary between the public and private sectors in healthcare. It runs as a small boutique with 11-50 employees.

What The Moran Company does

The Moran Company is a private, for-profit healthcare research and consulting firm founded in 1997 and headquartered in Arlington, Virginia, United States. Per its firmographic record, it operates at the boundary between the public and private sectors in healthcare, positioning itself as a specialized boutique advisory in a niche policy/research intersection. The firm maintains a small headcount of 11-50 employees and operates without disclosed funding rounds, parent entities, subsidiaries, or M&A history. Its website (www.themorancompany.com) is the only publicly cited channel, and no customer logos, case studies, awards, patents, partnerships, or leadership roster are disclosed in the available sources. The firm's core technology is listed as 'Not disclosed,' and no products, services detail, or pricing model are publicly available.

A material data conflict exists across sources: while firmographic data describes The Moran Company as a healthcare research and consulting firm, one independent source characterizes it as a nonprofit fundraising consultancy. The healthcare characterization is treated as primary because it appears in the structured firmographic record and is consistent with the company's own materials; the characterization is treated as either an unreliable signal or a reference to an unrelated entity. This conflict represents a meaningful gap that limits the precision of any external due diligence.

Given the absence of disclosed financials, customer references, service line detail, or management team information, the firm's business model, go-to-market mechanics, and revenue composition cannot be substantively described. The most defensible characterization is that it is a small, private, long-tenured healthcare policy/research consultancy whose specific service mix, client roster, and financial profile are not publicly documented in the supplied data.

The Moran Company firmographics

Firmographics
Name
The Moran Company
Legal name
The Moran Company
Website
https://themorancompany.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
11–50 employees
Short description
The Moran Company is a private healthcare research and consulting firm founded in 1997 in Arlington, Virginia, operating at the boundary between the public and private sectors in healthcare. It runs as a small boutique with 11-50 employees.
Ownership category
akta.pro rank

Where The Moran Company is headquartered

Location

Headquarters

HQ city
Arlington
HQ country
United States
HQ region
North America

Markets served

The Moran Company business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel

The Moran Company product offering

Product offering

Core offering

The Moran Company is a health care research and consulting firm that delivers advisory and research services at the intersection of the public and private sectors in health care. It supports organizations navigating policy, reimbursement, regulatory, and program-design challenges across the public-private health care boundary.

Differentiator

Problem solved

Functional benefit

Products and services

  • Health Care Research and Consulting Services Research and advisory consulting services for organizations operating at the intersection of public and private health care sectors, supporting work in policy, reimbursement, regulation, and program design.

Companies that use The Moran Company

Customer profile

Segments1 record

Ideal customer profiles1 record

The Moran Company technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Moran Company partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

The Moran Company competitors and assessment

Company assessment

Direct peers

  • Manatt Health: Manatt Health is the healthcare arm of Manatt, Phelps & Phillips, providing consulting and legal/regulatory advisory to health systems, plans, states, and federal agencies. It overlaps with Moran on Medicare/Medicaid policy, payment models, and strategy engagements for similar clients.
  • Health Management Associates (HMA): HMA is a healthcare research and consulting firm that advises payers, providers, states, and federal agencies on Medicaid, Medicare, and broader health policy. Like The Moran Company, it operates at the public/private intersection of US healthcare; HMA is materially larger but most directly comparable on dimension of service offering and end clients.
  • The Lewin Group: Lewin Group is a healthcare policy consulting and research practice advising federal agencies, states, health plans, and providers on payment, delivery system, and program design questions. Its research-driven approach at the public/private intersection places it as a close analogue to Moran.
  • Avalere Health: Avalere is a healthcare consulting and advisory firm focused on federal healthcare programs, reimbursement, and policy strategy. It serves the same payer, provider, and life-sciences clients with similar public/private sector advisory work, making it a strong direct comparison for Moran's policy and reimbursement analysis capabilities.
  • Wakely Consulting Group: Wakely is a healthcare actuarial and consulting firm serving health plans, providers, and federal/state agencies on Medicare, Medicaid, and ACA programs. Like Moran, it combines quantitative consulting with policy understanding for similar end clients in the public/private healthcare nexus.
  • Leavitt Partners: Leavitt Partners provides healthcare consulting and value-based-care strategy advisory to providers, payers, employers, and federal/state agencies. Shared positioning at the intersection of policy and commercial healthcare delivery makes it a relevant direct peer for similar consulting engagements.
  • Burns & Associates (now part of HMA): Burns & Associates is a health policy consulting firm serving state Medicaid agencies, health plans, and providers on payment, eligibility, and program design. It is a strong comparable given shared state/federal Medicaid policy advisory depth.

Broad incumbents

  • Advisory Board (now part of Optum): Advisory Board (Optum) is a large healthcare research and consulting firm serving hospital systems, payers, and life sciences. While broader in scope and substantially larger, its policy and strategy research offerings overlap with Moran's healthcare advisory scope.

Emerging players

  • Dobson DaVanzo & Associates: Dobson | DaVanzo is a healthcare economics and policy consulting firm providing reimbursement modeling, regulatory impact analysis, and litigation support to providers, payers, and government. Its reimbursement and policy-analytics focus mirrors a specific dimension of Moran's practice.
  • Health Policy Source: Health Policy Source is a Washington-area healthcare policy and reimbursement consulting firm serving providers, payers, and associations. Its specialty focus on payment policy and reimbursement strategy makes it a small-shop comparable in the same federal-program consulting niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

The Moran Company social profiles

Digital presence

The Moran Company financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Moran Company leadership team

Management profile

Number of profiles

The Moran Company funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Moran Company M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Moran Company

What does The Moran Company do?

The Moran Company is a health care research and consulting firm that delivers advisory and research services at the intersection of the public and private sectors in health care. It supports organizations navigating policy, reimbursement, regulatory, and program-design challenges across the public-private health care boundary.

Is The Moran Company a public or private company?

The Moran Company is a private company. It is classified as unknown and is currently operating.

When was The Moran Company founded?

The Moran Company was founded in 1997. It employs 11 to 50 people.

Where is The Moran Company based?

The Moran Company is headquartered in Arlington, United States, in the North America region.

Who are The Moran Company's main competitors?

Direct peers on record are Manatt Health, Health Management Associates (HMA), The Lewin Group, Avalere Health, Wakely Consulting Group, Leavitt Partners and Burns & Associates (now part of HMA). Advisory Board (now part of Optum) is listed as a broad incumbent. Emerging players are Dobson DaVanzo & Associates and Health Policy Source.

Does The Moran Company have an API?

No public API is recorded for The Moran Company.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHealth Management Associates Acquires The Moran CompanyHealth Management Associates (HMA) has acquired The Moran Company, a healthcare research and consulting firm based in Washington, D.C., as announced on July 7, 2021. This acquisition enhances HMA's services and capabilities in navigating the complex healthcare landscape, especially in Medicare systems. The integration aims to expand client offerings across the public and private sectors of healthcare.MorancompanyFour Ways to Fund a Nonprofit Executive SearchThe Moran Company, a nonprofit executive search firm, outlines four ways organizations can secure funding for professional recruitment of leadership or fundraising roles: capacity-building grants from private foundations, charitable gifts from board members or benefactors, endowment or reserve funds, and financial assistance from national partners or affiliates. The firm offers 30 minutes of free advice to all organizations regardless of budget.PR NewswireStudy Finds Hospitals Continue to Mark Up Medicines up to 500% of Their CostA study by the Moran Company, commissioned by PhRMA, found that hospitals charge an average of five times their cost for medicines, with markups reaching up to 500%. The analysis highlights significant profit margins in the 340B drug discount program, where hospitals retain substantial funds instead of using them solely for patient care as intended. This practice contributes to increased cost sharing and premiums for patients across the United States.PR NewswireNew Analysis Finds Average Sales Price System Has Led to Significant Cost Savings for Medicare and SeniorsThe Moran Company analysis found that the Average Sales Price (ASP) reimbursement system for Medicare Part B medicines saved the government and seniors $132 billion from 2005 to 2017, with prices for Part B medicines decreasing by 33.9 percent from 2003 to 2005 following implementation. The study was commissioned and published by the Pharmaceutical Research and Manufacturers of America (PhRMA), which is using the findings to advocate against changes to the Part B program. Additional findings include that Part B medicine spending represented just 8 percent of total Part B spending and 3 percent of total Medicare spending in 2016, with ASP reflecting a utilization-weighted average discount of more than 21 percent off the list price.PR NewswireNearly 1 in 5 Hospitals Marks Up Medicine Prices at Least 700 PercentA new analysis from The Moran Company, commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA), found that nearly one in five hospitals marks up medicine prices 700 percent or more, with some hospitals marking up prices more than 1,000 percent. The study, which used Centers for Medicare and Medicaid Services data covering 3,792 hospitals, found that average hospital markups on medicines were nearly 500 percent. PhRMA released the report as part of its 'Let's Talk About Cost' campaign, arguing that hospital markups contribute to rising healthcare costs for patients and insurers.PR NewswireStudy Shows Adherence To Physical Therapy Program For Low Back Pain Can Reduce Overall Medicare SpendThe Alliance for Physical Therapy Quality and Innovation (APTQI) released study findings showing that Medicare patients with lower back pain who complete multiple physical therapy visits incur 14–32 percent lower average total Medicare spending in the year following diagnosis compared to patients with only one visit. The independent analysis, conducted by The Moran Company, assessed 38,260 Medicare patients and found that those averaging 9.1 visits over eight weeks cost less overall than patients with a single therapy visit. The study argues that insurance design should remove barriers to physical therapy attendance, noting that outpatient therapy averaging $625 is less expensive than typical MRI or diagnostic costs.PR NewswireNew Report Indicates Revising CMS Policy on Biosimilars Could Save $11.4 Billion On Medicines Over 10 YearsThe Association for Accessible Medicines and its Biosimilars Council released an analysis by The Moran Company finding that revising the Centers for Medicare & Medicaid Services' biosimilar reimbursement policy could save the federal government $11.4 billion on medicines over 10 years. The current CMS policy groups all biosimilars of a reference biologic under a single billing code and payment rate, which the report argues would cause manufacturers to exit or avoid the market, ultimately leading to higher long-term costs despite short-term savings. CMS is currently assessing this policy and has solicited comments on proposed rule CMS-1676-P.PR NewswireStudy Reveals Early Physical Therapy Treatment Of Lower Back Pain Reduces Medicare OutlaysA study conducted by The Moran Company for the Alliance for Physical Therapy Quality and Innovation found that Medicare patients who received physical therapy as their first treatment for lower back pain had 19 percent lower total Medicare costs compared to those who initially received injections, and approximately 75 percent less than those who received surgery first. Patients who opted for physical therapy within 15 days of diagnosis saw 27 percent lower average costs due to fewer required follow-on health care services. The findings support physical therapy as a cost-effective first-line treatment for the condition, which affects more than 80 percent of the U.S. adult population.PR NewswireNew Moran Company Analysis of Medicare Home Health Beneficiary Population Underscores Need for Rural Safeguard ExtensionThe Moran Company released an analysis of Medicare home health beneficiaries finding that rural patients face greater health vulnerabilities, higher poverty rates, and reduced access to healthcare compared to urban counterparts, while rural care costs are 36 percent higher per visit. The Partnership for Quality Home Healthcare, which represents home health agencies across the U.S., is using these findings to urge Congress to extend the three percent rural safeguard payment adjustment for home health providers in rural areas, which is set to expire on December 31, 2017. The analysis shows rural beneficiaries are 15 percent less likely to receive home health services and travel more than twice the distance to reach doctors and hospitals compared to urban patients.PR NewswireStudy Finds That CMS Methodology Likely Understates Puerto Rico's Medicare Advantage (MA) BenchmarksA study by The Moran Company released on January 30, 2017 found that the Centers for Medicare and Medicaid Services (CMS) methodology for setting Medicare Advantage benchmarks in Puerto Rico likely understates funding due to selection bias, as the island's fee-for-service population (12% of eligible) is not representative of its larger MA population (75%+ enrollment). Puerto Rico's MA benchmark stands at $473 per beneficiary, 43% below the U.S. average of $830, with the island having lost approximately $4 billion in aggregate MA funding since 2011. The study, supported by letters from 16 members of Congress and Puerto Rico's Governor, calls on CMS to adjust its methodology to account for the marked differences between Puerto Rico's MA and traditional Medicare populations.